New Drug Delivery Method Targets Gut, Reduces IBD Medication Doses by Up to 10 Times- Study Dr. Garima Soni3 May 2025 8:00 AM ISTA new drug delivery technique, GlycoCaging, could transform the treatment of inflammatory bowel disease (IBD), allowing medication to be delivered...
GLP-1 Drugs May Increase Rejection Risk in Lung Transplant Recipients, Study Suggests Dr. Shravani Dali3 May 2025 7:30 AM ISTA recent study presented at the 2025 International Society for Heart and Lung Transplantation (ISHLT) annual meeting suggests that glucagon-like...
Exclusive E-Cigarette Use Linked to COPD and Hypertension in Adults, finds study Dr Riya Dave2 May 2025 8:15 PM ISTResearchers have identified in a new study that sole e-cigarette use is strongly linked with the risk of chronic obstructive pulmonary disease (COPD)...
Weekly Semaglutide Offers Long-Term Relief: Better Glycaemic Control and Less Insulin in Type 2 Diabetes, Study Finds Medha Baranwal2 May 2025 9:00 AM ISTItaly: A recent multicentre real-world study supports the long-term effectiveness of once-weekly semaglutide as a valuable addition to treatment...
Semaglutide has potential for treating fatty liver disease highlights VCU-led research Dr. Kamal Kant Kohli2 May 2025 8:30 AM ISTAn international study led by the director of Virginia Commonwealth University's liver institute suggests that the substance in Ozempic and Wegovy can...
Researchers Identify Blood Biomarkers Linked to Long COVID Symptoms Dr. Garima Soni2 May 2025 8:30 AM ISTA groundbreaking study from Karolinska Institutet, Sweden, and Cardiff University, UK, published in Nature Immunology, has identified specific blood...
Dolo 650: Popular Painkiller or Silent Liver Threat? Study Sheds Light Dr. Garima Soni2 May 2025 8:00 AM ISTDolo 650, a popular paracetamol brand, is commonly used to treat pain and fever in India. While it's generally safe when taken properly, overuse,...
FDA Approves Upadacitinib for Giant Cell Arteritis in Adults Dr. Kamal Kant Kohli2 May 2025 5:30 AM ISTThe FDA has approved upadacitinib, a Janus kinase inhibitor, for the treatment of giant cell arteritis in adults-marking the first new approval for...
Phase 3 Trial Backs Ivarmacitinib as Effective Oral Option for Moderate to Severe Atopic Dermatitis Medha Baranwal1 May 2025 9:15 PM ISTChina: A recent phase 3 randomized clinical trial has shown that ivarmacitinib significantly improves symptoms in adolescents and adults with moderate...
Smoking cessation drug varenicline helps young adults quit vaping: Study Dr. Kamal Kant Kohli1 May 2025 9:00 PM ISTA new study by investigators from Mass General Brigham showed that teens and young adults who took varenicline-an FDA-approved, twice-daily smoking...
Both Roux-en-Y gastric bypass bests sleeve gastrectomy for weight reduction, reveals research Jacinthlyn Sylvia1 May 2025 8:30 PM ISTA new study published in the journal of The Lancet Diabetology and Endocrinology revealed that with 68% of individuals obtaining at least 50%...
BCG Vaccine effetive in Reducing TB Risk in Children especially in Low-Incidence Areas: Meta-Analysis Medha Baranwal1 May 2025 8:00 PM ISTChina: A recent systematic review and meta-analysis has reaffirmed the protective effect of the Bacillus Calmette-Guerin (BCG) vaccine against...
